| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AIMT | Aimmune Therapeutics, Inc. | Oxtoby Andrew | Chief Commercial Officer | Oct 10, 2020 | Option Exercise | $34.50 | 6,345 | 218,903 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Oxtoby Andrew | Chief Commercial Officer | Oct 13, 2020 | Option Exercise | $34.50 | 20,250 | 698,625 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Oxtoby Andrew | Chief Commercial Officer | Sep 15, 2020 | Option Exercise | $34.25 | 840 | 28,770 | 26,595 | Sep 16, 2020, 05:19 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Oxtoby Andrew | Chief Commercial Officer | Mar 13, 2020 | Buy | $14.76 | 3,000 | 44,266 | 25,015 | Mar 17, 2020, 04:51 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Oxtoby Andrew | Chief Commercial Officer | Jan 22, 2020 | Option Exercise | $33.23 | 1,235 | 41,039 | 10,765 | Mar 04, 2020, 09:49 PM |
Menu